COST-EFFECTIVENESS ANALYSIS OF ISAVUCONAZOLE VERSUS VORICONAZOLE FOR THE TREATMENT OF INVASIVE ASPERGILLOSIS IN JORDAN

被引：0
|
作者：
Naser, A. [1 ]
Bilbisi, M. [2 ]
Mousa, R. [3 ]
机构：
[1] Isra Univ, Amman, Jordan
[2] Abdali Med Ctr, Amman, Jordan
[3] Univ Jordan, Fac Pharm, Amman, AM, Jordan
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE336
引用
收藏
页码：S116 / S116
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden
    Lefteris Floros
    Daniel Kuessner
    Jan Posthumus
    Emma Bagshaw
    Jan Sjölin
    BMC Infectious Diseases, 19
  • [2] Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden
    Floros, Lefteris
    Kuessner, Daniel
    Posthumus, Jan
    Bagshaw, Emma
    Sjolin, Jan
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [3] Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole as First-Line Treatment for Invasive Aspergillosis
    Rachel Harrington
    Edward Lee
    Hongbo Yang
    Jin Wei
    Andrew Messali
    Nkechi Azie
    Eric Q. Wu
    James Spalding
    Advances in Therapy, 2017, 34 : 207 - 220
  • [4] Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole as First-Line Treatment for Invasive Aspergillosis
    Harrington, Rachel
    Lee, Edward
    Yang, Hongbo
    Wei, Jin
    Messali, Andrew
    Azie, Nkechi
    Wu, Eric Q.
    Spalding, James
    ADVANCES IN THERAPY, 2017, 34 (01) : 207 - 220
  • [5] COST-EFFECTIVENESS ANALYSIS OF ISAVUCONAZOLE VERSUS LIPOSOMAL AMPHOTERICIN FOR THE TREATMENT OF INVASIVE MUCORMYCOSIS IN JORDAN
    Naser, A.
    Bilbisi, M.
    Mousa, R.
    VALUE IN HEALTH, 2023, 26 (12) : S145 - S145
  • [6] COST-EFFECTIVENESS ANALYSIS OF ISAVUCONAZOLE FOR THE TREATMENT OF INVASIVE ASPERGILLOSIS IN THE CZECH REPUBLIC
    Hajickova, B.
    Mlcoch, T.
    Dolezal, T.
    Charbonneau, C.
    Sung, A.
    Vothova, P.
    Mazan, P.
    Billova, S.
    VALUE IN HEALTH, 2018, 21 : S232 - S232
  • [7] Cost-effectiveness analysis of voriconazole versus amphotericin B in the treatment of invasive aspergillosis in Spain
    Grau, S
    Mateu-de, AJ
    Soto, J
    Muñoz, M
    Salas, E
    VALUE IN HEALTH, 2003, 6 (06) : 750 - 751
  • [8] Cost-effectiveness of voriconazole versus amphotericin B deoxicolate for the primary treatment of invasive aspergillosis
    Aiello, EC
    Devoto, FM
    Dignani, C
    De Vedia, L
    Lorenzo, H
    VALUE IN HEALTH, 2006, 9 (03) : A155 - A155
  • [9] COST-EFFECTIVENESS ANALYSIS OF VORICONAZOLE VERSUS AMPHOTERICIN B DEOXYCHOLATE IN THE TREATMENT OF INVASIVE PULMONARY ASPERGILLOSIS IN COLOMBIA
    Lemos, E., V
    Cortes, J.
    Gutierrez-Ardila, M., V
    Nunez, S. M.
    Prieto, H. A.
    VALUE IN HEALTH, 2012, 15 (04) : A243 - A243
  • [10] Comparative cost-effectiveness of voriconazole and amphotericin B in treatment of invasive pulmonary aspergillosis
    Greene, Reginald E.
    Mauskopf, Josephine
    Roberts, Craig S.
    Zyczynski, Teresa
    Schlamm, Haran T.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (24) : 2561 - 2568
12345